Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit
Journal of Neural Transmission2002Vol. 109(7-8), pp. 1053–1065
Citations Over TimeTop 1% of 2002 papers
Related Papers
- → Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles(2005)79 cited
- → Use of a novel radiometric method to assess the inhibitory effect of donepezil on acetylcholinesterase activity in minimally diluted tissue samples(2010)9 cited
- → Blood markers in Alzheimer disease: Subnormal acetylcholinesterase and butyrylcholinesterase in lymphocytes and erythrocytes(1994)40 cited
- → The role of cholinesterases in chagas disease(2022)3 cited
- → The alterations in cholinesterase activity (AChE and BChE) among the frequent cellphone users and non users: A pilot study(2011)